GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Twist Bioscience Corp (FRA:0ME) » Definitions » Earnings per Share (Diluted)

Twist Bioscience (FRA:0ME) Earnings per Share (Diluted) : €-3.11 (TTM As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Twist Bioscience Earnings per Share (Diluted)?

Twist Bioscience's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was €-0.73. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was €-3.11.

Twist Bioscience's EPS (Basic) for the three months ended in Mar. 2024 was €-0.73. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was €-3.11.

Twist Bioscience's EPS without NRI for the three months ended in Mar. 2024 was €-0.73. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was €-2.90.

During the past 3 years, the average EPS without NRIGrowth Rate was -3.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was -4.70% per year.

During the past 8 years, Twist Bioscience's highest 3-Year average EPS without NRI Growth Rate was 0.10% per year. The lowest was -18.60% per year. And the median was -3.70% per year.


Twist Bioscience Earnings per Share (Diluted) Historical Data

The historical data trend for Twist Bioscience's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Twist Bioscience Earnings per Share (Diluted) Chart

Twist Bioscience Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Earnings per Share (Diluted)
Get a 7-Day Free Trial -3.56 -3.03 -2.68 -4.08 -3.37

Twist Bioscience Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.97 -0.93 -0.76 -0.69 -0.73

Competitive Comparison of Twist Bioscience's Earnings per Share (Diluted)

For the Diagnostics & Research subindustry, Twist Bioscience's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Twist Bioscience's PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Twist Bioscience's PE Ratio distribution charts can be found below:

* The bar in red indicates where Twist Bioscience's PE Ratio falls into.



Twist Bioscience Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Twist Bioscience's Earnings Per Share (Diluted) for the fiscal year that ended in Sep. 2023 is calculated as

Diluted Earnings Per Share (A: Sep. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-191.727-0)/56.885
=-3.37

Twist Bioscience's Earnings Per Share (Diluted) for the quarter that ended in Mar. 2024 is calculated as

Diluted Earnings Per Share (Q: Mar. 2024 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-41.853-0)/57.779
=-0.72

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-3.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Twist Bioscience  (FRA:0ME) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Twist Bioscience Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Twist Bioscience's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Twist Bioscience (FRA:0ME) Business Description

Traded in Other Exchanges
Address
681 Gateway Boulevard, South San Francisco, CA, USA, 94080
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of its revenue from the United States.

Twist Bioscience (FRA:0ME) Headlines

No Headlines